Voyager Technologies (VOYG) shares more than doubled Wednesday in their debut on the New York Stock Exchange after the initial public offering of 12.3 million class A shares priced at $31 apiece.
More than 10.8 million shares of the company traded intraday.
Kazia Therapeutics (KZIA) said Wednesday that preclinical data on paxalisib showed the drug's potential to reprogram the tumor microenvironment and improve immune response in triple-negative breast cancer.
Shares soared 78% as intraday trading volume soared to over 43.4 million from a daily average of roughly 29,000.
Ouster (OUST) said Wednesday that the US Department of Defense has vetted and approved the company's OS1 digital lidar for use in unmanned aerial systems.
Shares advanced 29% as intraday trading volume climbed to more than 13.4 million from a daily average of about 1.6 million.
Price: 63.00, Change: +32.00, Percent Change: +103.23
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.